SEC FORM 4
$215,958.91
UNITED THERAPEUTICS Corp (UTHR)
Sale of 401 shares at $538.5509 per share.
Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S
Traded Oct 16, 2026 · Disclosed Oct 19, 2026
Source: SEC Form 4 · 0001106578-26-000166 · filed 2026-10-19 · View filing →